AU
TMO icon

Algebris (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Algebris (UK)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,747
Closed -$878K – 48
2024
Q4 		$878K Buy
+1,747
New +$961K 0.22% 36
2024
Q3 		– Sell
-1,575
Closed -$813K – 46
2024
Q2 		$813K Buy
1,575
+461
+41% +$264K 0.26% 39
2024
Q1 		$600K Sell
1,114
-250
-18% -$140K 0.27% 40
2023
Q4 		$656K Buy
1,364
+499
+58% +$242K 0.34% 22
2023
Q3 		$439K Buy
865
+133
+18% +$70.9K 0.22% 34
2023
Q2 		$380K Sell
732
-230
-24% -$124K 0.19% 35
2023
Q1 		$556K Sell
962
-5
-0.5% -$2.82K 0.22% 31
2022
Q4 		$531K Buy
+967
New +$512K 0.24% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Algebris (UK)'s TMO Position: Q1 2025 in Review

Algebris (UK) sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 1,747 shares — an estimated $878K sold.

Algebris (UK) first reported a position in TMO in Q4 2022 and held it in 8 quarters. The position peaked at $878K in Q4 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Algebris (UK) reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Algebris (UK) sold 1,747 Thermo Fisher Scientific shares in Q1 2025, an estimated $878K.
  • Algebris (UK) first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 8 quarters.
  • Algebris (UK)'s Thermo Fisher Scientific position peaked at $878K in Q4 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Algebris (UK)'s 13F filing for Q1 2025, filed 8 May 2025.